EXHIBIT 99.7
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ENACTED PURSUANT TO
SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002
FSD Pharma Inc. (the "Company") is filing with the U.S. Securities and Exchange Commission on the date hereof, amendment no. 1 to its annual report on Form 40-F for the fiscal year ended December 31, 2019 (the "Report").
I, Raza Bokhari, Executive Co-Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as enacted pursuant to section 906 of the U.S. Sarbanes-Oxley Act of 2002, that:
(i) | the Report fully complies with the requirements of section 13(a) or 15(d) of the U.S. Securities Exchange Act of 1934; and |
(ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
/s/ Raza Bokhari |
Name: Raza Bokhari |
Title: Executive Co-Chairman and Chief Executive Officer |
Date: March 17, 2020 |
